1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respirat Crit Care Med. 2001; 163(7):1723-9.
2. Latini G, De Felice C, Giannuzzi R, Del Vecchio A. Survival rate and prevalence of bronchopulmonary
dysplasia in extremely low birth weight infants. Early Hum Dev. 2013; 89(Suppl 1):S69-73.
3. Nobile S, Marchionni P, Vento G, Vendettuoli V, Marabini C, Lio A, et al. New insights on early patterns of respiratory disease among extremely low gestational age newborns. Neonatology. 2017; 112(1):53-9.
4. Nobile S, Marchionni P, Carnielli VP. Neonatal outcome of small for gestational age preterm infants. Eur J Pediatr. 2017; 176(8):1083-8.
5. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004; 114(5):1305-11.
6. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001; 163(7):1723-9.
7. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988; 82(4):527-32.
8. Nobile S, Marchionni P, Gidiucci C, Correani A, Palazzi ML, Spagnoli C, et al. Oxygen saturation/ FIO2 ratio at 36 weeks’ PMA in 1,005 preterm infants: effect of gestational age and early respiratory disease patterns. Pediatr Pulmonol. 2019; 54(5):637-43.
9. Palta M, Sadek-Badawi M, Sheehy M, Albanese A, Weinstein M, McGuinness G, et al. Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol. 2001; 154(6):521-9.
10. Gerhardt T, Hehre D, Feller R, Reifenberg L, Bancalari E. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr. 1987; 110(3):448-56.
11. Allen J, Zwerdling R, Ehrenkranz R, Gaultier C, Geggel R, Greenough A, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003; 168(3):356-96.
12. Baraldi E, Carraro S, Filippone M. Broncho-pulmonary dysplasia: definitions and long-term respiratory outcome. Early Hum Dev. 2009; 85(10 Suppl):S1-3.
13. Committee on Infectious Diseases. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009; 124(6):1694-701.
14. Nobile S, Gnocchini F, Pantanetti M, Battistini P, Carnielli VP: The importance of oxygen control reaffirmed: experience of ROP reduction at a single tertiary-care NICU. J Pediatr Ophtalmol Strab. 2014; 51(2):112-5.